AMRX
Amneal Pharmaceuticals, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$17.44
−2.41%Margins
Gross margin
39.3%
EBITDA margin
20.9%
EBIT margin
12.9%
Net margin
5.0%
FCF margin
2.7%
476.5%
Return on equity
4.2%
Return on assets
14.3%
Return on invested capital
0.85x
Asset turnover
$200.8M
Cash from operations
$0.40
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026